Edman degradation
The Edman degradation is a method of protein sequencing that allows for the sequential identification of amino acids in a peptide. This technique was developed by Pehr Edman in the 1950s and has been a fundamental tool in biochemistry for determining the primary structure of proteins.
Principle[edit]
The Edman degradation involves the selective cleavage of the N-terminal amino acid of a peptide, which is then identified as a phenylthiohydantoin (PTH) derivative. This process can be repeated multiple times to sequence the entire peptide.
Step 1: Coupling[edit]
In the first step, the peptide is treated with phenyl isothiocyanate (PITC) under mildly alkaline conditions. This reagent reacts with the free amino group of the N-terminal amino acid to form a phenylthiocarbamoyl derivative.
Step 2: Cleavage[edit]
The peptide is then treated with anhydrous acid, typically trifluoroacetic acid (TFA), which cleaves the N-terminal amino acid as a cyclic phenylthiohydantoin (PTH) derivative, leaving the rest of the peptide intact.
Step 3: Identification[edit]
The PTH-amino acid is identified using chromatography or mass spectrometry. This identification step is crucial for determining the sequence of the peptide.
Advantages and Limitations[edit]
The Edman degradation is advantageous for its ability to sequence peptides with high accuracy. However, it has limitations, such as the inability to sequence peptides longer than about 50 residues due to incomplete cleavage and side reactions. Additionally, it requires a free N-terminal amino group, which may not be available in all peptides.
Applications[edit]
Edman degradation has been widely used in the field of proteomics for the analysis of protein structure and function. It has been instrumental in the sequencing of many important proteins and in the study of enzyme mechanisms.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian